{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:20:59Z","timestamp":1791105659689,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/exnr.2001.7727","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"139-146","source":"Crossref","is-referenced-by-count":115,"title":["\u03bc- and \u03b4-Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease"],"prefix":"10.1006","volume":"171","author":[{"given":"Brian","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brotchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2001.7727_RF1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s007020050192","article-title":"Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica","volume":"106","author":"Berg","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.2001.7727_RF2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/oxfordjournals.jbchem.a022331","article-title":"Dymorphin A processing enzyme: Tissue distribution, isolation, and characterization","volume":"125","author":"Berman","year":"1999","journal-title":"J. Biochem."},{"key":"10.1006\/exnr.2001.7727_RF3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1126\/science.205949","article-title":"Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone","volume":"200","author":"Biggio","year":"1978","journal-title":"Science"},{"key":"10.1006\/exnr.2001.7727_RF4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002826-198409000-00008","article-title":"Naloxone may be beneficial in the treatment of tardive dyskinesia","volume":"7","author":"Blum","year":"1984","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/exnr.2001.7727_RF5","first-page":"41","article-title":"Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease","volume":"78","author":"Brotchie","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF6","first-page":"40","article-title":"Quantitative assessment of dyskinesias in subhuman primates","volume":"14","author":"Brotchie","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF7","first-page":"273","article-title":"Review of naltrexone, a long-acting opiate antagonist","volume":"3","author":"Crabtree","year":"1984","journal-title":"Clin. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870050203","article-title":"A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment","volume":"5","author":"Crossman","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/271178a0","article-title":"Evidence for a long Leu-enkephalin striopallidal pathway in rat brain","volume":"271","author":"Cuello","year":"1978","journal-title":"Nature"},{"key":"10.1006\/exnr.2001.7727_RF10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(82)90003-8","article-title":"Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus","volume":"231","author":"Del Fiacco","year":"1982","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF11","first-page":"567","article-title":"International Union of Pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol. Rev."},{"key":"10.1006\/exnr.2001.7727_RF12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/exnr.1997.6431","article-title":"Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression","volume":"144","author":"Duty","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF13","first-page":"1630","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes","volume":"271","author":"Emmerson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.2001.7727_RF14","first-page":"152","article-title":"Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism","volume":"547","author":"Filion","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(88)91217-6","article-title":"Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study","volume":"460","author":"Gerfen","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1006\/exnr.2001.7727_RF17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","article-title":"The neostriatal mosaic: Multiple levels of compartmental organization","volume":"15","author":"Gerfen","year":"1992","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2001.7727_RF18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mds.870090403","article-title":"Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter- and intrarater reliability assessment","volume":"9","author":"Goetz","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on l-dopa-induced dyskinesias in MPTP-treated monkeys","volume":"16","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/exnr.2001.7727_RF20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0306-4522(81)90188-3","article-title":"Correlation between Met-enkephalin and substance P immunoreactivity in the primate globus pallidus","volume":"6","author":"Haber","year":"1981","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7727_RF21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002512-199609030-00001","article-title":"Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease","volume":"9","author":"Henry","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1006\/exnr.2001.7727_RF22","unstructured":"Henry, B, A. R. Crossman, and, J. M. Brotchie, 1997, Topographical increases in striatal pre-proenkephalin-B (PPE-B) expression associated with dopamine agonist-induced dyskinesia in the parkinsonian (MPTP) primate. Anatomical Society of Great Britain and Ireland, p, S17. [Abstract]"},{"key":"10.1006\/exnr.2001.7727_RF23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7","article-title":"The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of l-dopa in the MPTP-lesioned primate model of Parkinson's disease","volume":"14","author":"Henry","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF26","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(95)00385-X","article-title":"Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum","volume":"281","author":"Hill","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF27","series-title":"The Basal Ganglia V","first-page":"165","article-title":"Modulation of glutamate transmission in the basal ganglia by enadoline, a selective kappa-opioid receptor agonist, in the marmoset and rat","author":"Hill","year":"1996"},{"key":"10.1006\/exnr.2001.7727_RF28","first-page":"291.5","article-title":"A novel therapeutic approach to the symptomatic treatment of Parkinson's disease based on activation of delta opioid receptors","volume":"23","author":"Hille","year":"1997","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1006\/exnr.2001.7727_RF29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/exnr.1996.6380","article-title":"Problems with current pharmacologic treatment of Parkinson's disease","volume":"144","author":"Hurtig","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02244293","article-title":"Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice","volume":"103","author":"Jackson","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1006\/exnr.2001.7727_RF31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1006\/exnr.2001.7727_RF32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0166-4328(80)90043-1","article-title":"Interactions between d-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat","volume":"1","author":"Kelley","year":"1980","journal-title":"Behav. Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.410300105","article-title":"A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome","volume":"30","author":"Kurlan","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.307.6902.469","article-title":"Comparison of therapeutic effects of levodopa, levodopa and selegiline and bromocriptine in patients with early, mild Parkinson's disease: Three year interim report","volume":"307","author":"Lees","year":"1993","journal-title":"BMJ"},{"key":"10.1006\/exnr.2001.7727_RF35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1073\/pnas.87.1.230","article-title":"Dopamine receptor gene expression by enkephalin neurons in rat forebrain","volume":"87","author":"Le Moine","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2001.7727_RF36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-1781(88)90083-2","article-title":"High-dose naloxone in tardive dyskinesia","volume":"26","author":"Lindenmayer","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1006\/exnr.2001.7727_RF37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00495865","article-title":"The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties","volume":"319","author":"Magnan","year":"1982","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF38","first-page":"73","article-title":"Selectivity profile of nor-binaltorphimine and ICI-197,067 in guinea pig brain","volume":"328","author":"Magnan","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1006\/exnr.2001.7727_RF39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/exnr.1994.1007","article-title":"On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus","volume":"125","author":"Maneuf","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870090103","article-title":"Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology","volume":"9","author":"Marconi","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(99)00610-X","article-title":"Mu-opioid receptor specific antagonist cyprodime: Characterization by in vitro radioligand and [35S]GTPgammaS binding assays","volume":"383","author":"Marki","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-4522(94)00484-M","article-title":"Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum","volume":"65","author":"Matsumura","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7727_RF43","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/112.6.1533","article-title":"The role of the subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies","volume":"112","author":"Mitchell","year":"1989","journal-title":"Brain"},{"key":"10.1006\/exnr.2001.7727_RF44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/brain\/115.3.809","article-title":"A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia","volume":"115","author":"Mitchell","year":"1992","journal-title":"Brain"},{"key":"10.1006\/exnr.2001.7727_RF45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00008877-199508000-00010","article-title":"Reversal of parkinsonian symptoms by intrastriatal and systemic manipulation of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA-lesioned marmoset","volume":"6","author":"Mitchell","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-328X(97)00123-X","article-title":"Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: Comparison with l-DOPA therapy","volume":"49","author":"Morissette","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(95)00644-3","article-title":"Antinociceptive and behavioral effects of synthetic deltorphin analogs","volume":"296","author":"Negri","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2001.7727_RF48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00001756-199702100-00018","article-title":"A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease","volume":"8","author":"Newman","year":"1997","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.2001.7727_RF49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: Review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/exnr.2001.7727_RF50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0306-4522(93)90462-O","article-title":"Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey","volume":"55","author":"Page","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7727_RF51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q","article-title":"Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesia","volume":"46","author":"Papa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/mds.870100606","article-title":"Chronic l-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus)","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF53","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.870090410","article-title":"Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease","volume":"9","author":"Rascol","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7727_RF55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/brain\/121.3.527","article-title":"Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia","volume":"121","author":"Rascol","year":"1998","journal-title":"Brain"},{"key":"10.1006\/exnr.2001.7727_RF56","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.2001.7727_RF57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0196-9781(97)00025-9","article-title":"Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus","volume":"18","author":"Sandin","year":"1997","journal-title":"Peptides"},{"key":"10.1006\/exnr.2001.7727_RF58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/ajp.143.1.118a","article-title":"Naloxone treatment of l-dopa-induced dyskinesias in Parkinson's disease","volume":"143","author":"Sandyk","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1006\/exnr.2001.7727_RF59","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1046\/j.1471-4159.1996.67062292.x","article-title":"Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens","volume":"67","author":"Schad","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2001.7727_RF60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/jm00122a021","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (\u2212)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist","volume":"32","author":"Schmidhammer","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1006\/exnr.2001.7727_RF61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002826-199704000-00001","article-title":"Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias","volume":"20","author":"Stocchi","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1006\/exnr.2001.7727_RF62","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0024-3205(89)90470-0","article-title":"Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model","volume":"44","author":"Tortella","year":"1989","journal-title":"Life Sci."},{"key":"10.1006\/exnr.2001.7727_RF63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archneur.1982.00510140054014","article-title":"Effect of naloxone on the \u201con\u2013off\u201d syndrome in patients receiving long-term levodopa therapy","volume":"39","author":"Trabucchi","year":"1982","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.2001.7727_RF64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(96)00238-7","article-title":"Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra","volume":"725","author":"Trugman","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02245946","article-title":"Morphine and naltrexone modulate D2 but not D1 receptor induced motor behaviour in MPTP-lesioned monkeys","volume":"118","author":"Vermeulen","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1006\/exnr.2001.7727_RF66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-3057(95)02043-8","article-title":"Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay","volume":"53","author":"Wettstein","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1006\/exnr.2001.7727_RF67","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0306-4522(99)00046-9","article-title":"Fentanyl increases dopamine release in rat nucleus accumbens: Involvement of mesolimbic mu- and delta-2-opioid receptors","volume":"4","author":"Yoshida","year":"1999","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7727_RF68","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-8993(95)01402-0","article-title":"Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats","volume":"710","author":"You","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7727_RF69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488601977271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488601977271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T13:24:28Z","timestamp":1557321868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488601977271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0014488601977271"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2001.7727","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}